Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

Covid test stocks

Ready to invest in the COVID-19 testing industry? Consider these 9 stocks.

The COVID-19 pandemic triggered massive volatility in the stock market, with increased instability in recent weeks as surging cases have led to a rush of people looking for tests. We've rounded up 9 stocks in companies that produce or sell COVID tests.

The best stocks depend on your portfolio and investment goals. While volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

9 COVID test stocks to watch

We round up a selection of stocks in or related to the COVID-19 testing industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

  1. Abbott Laboratories (ABT)
  2. Quidel Corporation (QDEL)
  3. Cue Health IncCommon Stock (HLTH)
  4. Lucira Health (LHDX)
  5. Walgreens Boots Alliance (WBA)
  6. CVS Health Corporation (CVS)
  7. Agilent Technologies (A)
  8. Hologic (HOLX)
  9. Laboratory Corporation of America (LH)

Our top brokers for active traders

If you’ve outgrown your current trading platform and are looking for more advanced tools and data, here are our top picks for a second account.

Take a deeper dive into COVID test stocks

If you're interested in investing in the COVID-19 testing industry, take a closer look at what companies in this industry do and how the stocks have historically performed. Keep in mind that positive past performance doesn't guarantee that a stock will continue to rise in the future.

1. Abbott Laboratories (ABT)

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock opened the day at $134.88 after a previous close of $135.14. The latest price was $135.56 (25-minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD42.3 billion and employs 109,000 staff.

  • Market capitalization: $226,624,061,440
  • P/E ratio: 31.8015
  • PEG ratio: 2.6196

Back to top


2. Quidel Corporation (QDEL)

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine.

Quidel Corporation stock opened the day at $122.34 after a previous close of $121.25. The latest price was $123.00 (25-minute delay). Quidel Corporation is listed on the NASDAQ, has a trailing 12-month revenue of around USD$1.9 billion and employs 1,370 staff.

  • Market capitalization: $4,788,876,288
  • P/E ratio: 5.5632
  • PEG ratio: 7.19

Back to top


3. Cue Health IncCommon Stock (HLTH)

Cue Health Inc. , a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for public sectors, healthcare providers, large enterprises, and individual consumers. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System comprising a portable and reusable reader (Cue Reader), a single-use test cartridge (Cue Cartridge), and a sample collection wand (Cue Wand); Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows for integrations with third-party applications and sensors.

Cue Health IncCommon Stock stock opened the day at $9.80 after a previous close of $9.79. The latest price was $9.27 (25-minute delay). Cue Health IncCommon Stock is listed on the NASDAQ, has a trailing 12-month revenue of around USD$438.9 million and employs 1,290 staff.

  • Market capitalization: $1,492,902,656

Back to top


4. Lucira Health (LHDX)

Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services.

Lucira Health stock opened the day at $6.56 after a previous close of $6.58. The latest price was $8.50 (25-minute delay). Lucira Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$32.2 million and employs 102 staff.

  • Market capitalization: $252,214,176

Back to top


5. Walgreens Boots Alliance (WBA)

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International.

Walgreens Boots Alliance stock opened the day at $49.61 after a previous close of $49.17. The latest price was $49.50 (25-minute delay). Walgreens Boots Alliance is listed on the NASDAQ, has a trailing 12-month revenue of around USD$135 billion and employs 202,000 staff.

  • Market capitalization: $46,875,668,480
  • P/E ratio: 7.321
  • PEG ratio: 12.0008

Back to top


6. CVS Health Corporation (CVS)

CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals.

CVS Health Corporation stock opened the day at $90.64 after a previous close of $89.99. The latest price was $90.87 (25-minute delay). CVS Health Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$284 billion and employs 213,000 staff.

  • Market capitalization: $140,216,600,000
  • P/E ratio: 16.8246
  • PEG ratio: 2.0889

Back to top


7. Agilent Technologies (A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Agilent Technologies stock opened the day at $157.29 after a previous close of $156.78. The latest price was $157.80 (25-minute delay). Agilent Technologies is listed on the NYSE, has a trailing 12-month revenue of around USD$6.3 billion and employs 17,000 staff.

  • Market capitalization: $43,693,502,464
  • P/E ratio: 36.7208
  • PEG ratio: 2.1606

Back to top


8. Hologic (HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

Hologic stock opened the day at $76.48 after a previous close of $76.62. The latest price was $76.56 (25-minute delay). Hologic is listed on the NASDAQ, has a trailing 12-month revenue of around USD$5.6 billion and employs 6,705 staff.

  • Market capitalization: $17,496,385,536
  • P/E ratio: 9.6519
  • PEG ratio: 0.8737

Back to top


9. Laboratory Corporation of America (LH)

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Laboratory Corporation of America stock opened the day at $313.24 after a previous close of $313.34. The latest price was $314.21 (25-minute delay). Laboratory Corporation of America is listed on the NYSE, has a trailing 12-month revenue of around USD$16.6 billion and employs 70,000 staff.

  • Market capitalization: $26,420,854,784
  • P/E ratio: 9.7946
  • PEG ratio: 2.0681

Back to top

How to buy COVID test stocks

Sign up with an online broker or platform to invest in one or more of these COVID test stocks.

  1. Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like ABT or CVS.
  4. Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
  5. Choose an order type. Invest in the COVID test stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
  6. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the COVID-19 testing industry, track how your stock performs to decide when it’s time to sell.

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in COVID test stocks.
Name Product Asset types Signup bonus
M1 Finance
Stocks
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Bottom line

While it’s possible to turn a profit investing in COVID test stocks, keep in mind that — like any investment — COVID test stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the COVID-19 testing industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site